Abstract:Background: Recent evidence suggests that aberrant activation of Hedgehog (Hh) signaling by Gli transcription factors is characteristic of a variety of aggressive human carcinomas including gastric cancer. Speckle-type POZ protein, SPOP, is an E3 ubiquitin ligase adaptor, and it is found to inhibit oncogenic signaling. However, the molecular mechanisms are largely unknown.Methods: In this study, we characterized the expression of SPOP in 88 pairs of gastric cancer tissues and adjacent tissues by immunohistochemical staining and Western blotting. The relationship between SPOP expression and clinical pathologic factors was analyzed. Transfected gastric cancer cell lines were used in cell viability, wound healing and colony formation assays. The interaction of SPOP with Gli2 and other related apoptotic proteins was assessed by immunoprecipitation, Western blotting, real-time PCR and dual luciferase reporter assays. Intracellular interaction of SPOP and Gli2 was visualized by immunofluorescent staining in gastric cancer cells.Results: Immunohistochemical staining of SPOP can be detected in gastric cancer tissues but much less than adjacent gastric tissues (P < 0.01). High SPOP expression is negatively correlated with lymph node metastasis, poor histological differentiation, and tumor malignancy according to TNM staging. In vitro experiments revealed that over-expression of SPOP prevented tumor cells from proliferation, migration and colony formation in gastric cancer cell lines. Likewise, repression of SPOP promoted cell viability, migration, proliferation, and attenuated apoptosis. Mechanistic studies revealed that increasing SPOP accelerated Gli2 degradation but regardless of Gli2 synthesis. Furthermore, cytoplasmic Gli2 decreased markedly along with the abundant expression of SPOP in MKN45 cells.Conclusions: Our findings indicate that SPOP plays critical roles in suppressing gastric tumorigenesis through inhibiting Hh/Gli2 signaling pathway. It may provide an alternative strategy for developing therapeutic agents of gastric cancer in future.

SPOP regulates the DNA damage response and lung adenocarcinoma cell response to radiation.

Speckle-type POZ protein, SPOP, is involved in the DNA damage response.

Functional roles of Speckle-Type Poz (SPOP) Protein in Genomic stability

Speckle-type POZ adaptor protein (SPOP) and its role in cancer

The diverse roles of SPOP in prostate cancer and kidney cancer

Prostate cancer-associated SPOP mutations lead to genomic instability through disruption of the SPOP–HIPK2 axis

The emerging role of SPOP protein in tumorigenesis and cancer therapy

SPOP Promotes Tumorigenesis by Acting As a Key Regulatory Hub in Kidney Cancer

LRP5 competes for SPOP binding to enhance tumorigenesis mediated by Daxx and PD-L1 in prostate cancer

Speckle-type POZ protein functions as a tumor suppressor in non-small cell lung cancer due to DNA methylation

SPOP Suppresses Pancreatic Cancer Progression by Promoting the Degradation of NANOG.

Decreased expression of speckle-type POZ protein for the prediction of poor prognosis in patients with non-small cell lung cancer

SPOP Suppresses Tumorigenesis by Regulating Hedgehog/Gli2 Signaling Pathway in Gastric Cancer.

DECREASED EXPRESSION OF THE SPECKLE-TYPE POZ PROTEIN IS ASSOCIATED WITH POOR PROGNOSIS IN BLADDER CANCER

SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression

Speckle-type POZ Protein is Negatively Associated with Malignancies and Inhibits Cell Proliferation and Migration in Liver Cancer

SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway

Prostate Cancer-Associated Mutation in SPOP Impairs Its Ability to Target Cdc20 for Poly-Ubiquitination and Degradation.

Higher-order SPOP assembly reveals a basis for cancer mutant dysregulation

SPOP Promotes Tumor Progression Via Activation of Β-Catenin/tcf4 Complex in Clear Cell Renal Cell Carcinoma.

SPOP Inhibits BRAF-dependent Tumorigenesis Through Promoting Non-Degradative Ubiquitination of BRAF